|
|
|
31.10.25 - 12:42
|
Otsuka 9-Month Profit Climbs On Higher Sales (AFX)
|
|
|
TOKYO (dpa-AFX) - Otsuka Corp. (4768.T) on Friday reported higher profit for the nine months ended September 30, 2025, supported by increase in sales.Profit before tax rose 26.1% to 68.023 billion......
|
|
|
31.10.25 - 11:00
|
TIS H1 Profit, Sales Increase (AFX)
|
|
|
TOKYO (dpa-AFX) - For the six months ended September 30, 2025, TIS Inc. (TISNF) reported higher profit as well as sales.Profit before tax rose to 36.417 billion yen from 32.087 billion yen in the ......
|
|
|
|
|
|
|
|
|
29.10.25 - 11:30
|
SCSK Profit Rises In HY (AFX)
|
|
|
TOKYO (dpa-AFX) - SCSK Corp. (SCSKF.PK), Wednesday announced financial results for the six months of the fiscal year 2025.For the year ended September 30, 2025, the company reported profit of 35.6......
|
|
|
|
|
|
|
|
|
|
|
23.10.25 - 06:30
|
Midday Takeaway: HSI Closes Midday at 25,759, Down 22 pts; HSTI Closes Midday at 5,875, Down 47 pts; POP MART Down over 9%; PETROCHINA, NISSIN FOODS Hit New Highs (AAStocks)
|
|
|
At midday close, HSI dropped 22 pts or 0.1% to 25,759. HSTI dropped 47 pts or 0.8% to 5,875. HSCEI fell 17 pts or 0.2% to 9,206.Active Heavyweights:MEITUAN (03690.HK) closed at $97.45, up 1.4%XIAOMI (01810.HK) closed at $45.92, down 0.9%TENCENT (00700.HK) closed at $625.5, up 0.3%BABA (09988.HK) closed at $162.3, up 0.2%HSI & HS......
|
|
|
22.10.25 - 23:03
|
Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participações S.A. Debentures (Business Wire)
|
|
|
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank, to repurchase all 150,000 Series A Perpetual Convertible Preferred Shares of a nominal or par value of US$0.00005 each in the capital of the Company (the "Series A Preferred Shares") for an aggregate purchase price of R$831.6 million. The transaction is expected to close on November 3, 2025.
On April 26, 2021, the Company issued and sold 150,000 Series A Preferred Shares, equivalent to US$150.0 million in Reais, to Softbank. Afya intends to cancel all Series A Preferred Shares upon completion of the repurchase.
Afya also announced today that it has repaid in full on October 22, 2025, the R$500.0 million aggregate amount outstanding related to the first issuance of debentures by Af...
|
|
|
22.10.25 - 15:06
|
inDrive Appoints Jeri Doris as First Independent Board Director (Business Wire)
|
|
|
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--inDrive, the global mobility and urban-services platform, has appointed Jeri Doris as its first independent member of the Board of Directors.
Jeri Doris is Chief People Officer at New York-based Justworks, where she leads the People, Workplace, and DEIB teams. A certified executive coach and global HR leader, she has spent more than two decades helping organizations build inclusive, high-performing workplaces across almost every continent.
Before joining Justworks, Doris led people and culture teams at The Aspen Group, Delivery Hero, Rakuten, Groupon, Deloitte, and GE. She brings deep experience in people strategy, engagement, and organizational growth, and is a long-time advocate for mental health, women in leadership, and the future of work.
Doris will advise the Board and CEO on people and culture strategy, leadership development, and workforce wellbeing. She will help align talent priorities with long-term business goals, offer independent perspective and suppor...
|
|
|
|
|
22.10.25 - 12:30
|
Gold Prices Stable After Fall, Google Cloud AI Deal | The Pulse 10/22 (Bloomberg)
|
|
|
Gold and silver steadied, after suffering their steepest selloffs in years on Tuesday as concern their dizzying rallies in recent weeks had left them overvalued. In the world of tech, Bloomberg understands AI firm Anthropic and Google are in advanced talks over a cloud computing partnership potentially worth tens of billions of dollars. And European nations are working with Ukraine on a 12-point proposal to end Russia's war along current battle lines, pushing back against Putin's renewed demands to the US for Kyiv to surrender territory in return for a peace deal.
Today's guests: Derek Halpenny, Global Markets Head of Research at MUFG, Adrian Cox, Thematic Strategist at Deutsche Bank Research, Anna Rosenberg, Head of Geopolitics at Amundi Investment Institute. (Source: Bloomberg)...
|
|
|
21.10.25 - 20:12
|
Festive sales boom: Tata Motors delivers over 1 lakh vehicles between Navratri & Diwali (Times of India)
|
|
|
Tata Motors Passenger Vehicles Ltd celebrated a significant festive season, delivering over 1 lakh vehicles between Navratri and Diwali, a 33% year-on-year increase. SUVs, particularly the Nexon and Punch, led the surge, while electric vehicles also saw strong demand, crossing 10,000 units. This performance highlights robust market sentiment and Tata Motors' strategic focus on product leadership....
|
|
|
21.10.25 - 10:03
|
NTT DATA Strengthens Global Insurance Leadership with Acquisition of Alchemy Technology Services (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--NTT DATA, a global leader in AI, digital business and technology services, today announced the acquisition of Alchemy Technology Services, a specialist insurance technology consultancy. The move reinforces NTT DATA's commitment to transforming the global insurance ecosystem, addressing current and emerging challenges around agility, modernization and scalability. In addition to its strong consultancy and Guidewire credentials, Alchemy brings deep expertise in the specialty insurance market, particularly in supporting complex and regulated environments, such as the London Market, the largest (re)insurance subscription market globally. This will further strengthen NTT DATA's ability to serve niche and high-value segments across the global insurance landscape.
A shared vision for insurance innovation
This acquisition marks a significant milestone in NTT DATA's strategy to lead the digital reinvention of the insurance sector - a market set to reach $230.7 billion in IT spend this y...
|
|
|
|
|
20.10.25 - 10:06
|
RWS Appoints Industry Trailblazer Michael Wayne as Head of Media and Entertainment (Business Wire)
|
|
|
Appointment of former executive at Papercup, Sony Pictures Entertainment and ABC Television underscores RWS's investment in AI-powered media localizationMAIDENHEAD, England--(BUSINESS WIRE)--RWS, a content solutions company, powered by technology and human expertise, has named Michael Wayne as Head of Media and Entertainment, a move that underscores the company's ambition to transform the future of AI-powered media localization.
Based in Los Angeles, Michael joins RWS today to lead the company's fast-growing media localization business which includes AI dubbing, subtitling and end-to-end content adaptation. His appointment reflects RWS's accelerated investment in video localization — an area that blends cutting-edge AI with human creativity to help global brands connect with audiences across languages and cultures.
“We're truly excited to have such an industry pioneer and trailblazer join the team,” said Ben Faes, CEO of RWS. “His combination of creative vision and commercial acumen will supe...
|
|
|
17.10.25 - 15:27
|
Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Dimitri Azar, MD, MBA, AM (hon.), DHL (hon.), to its Board of Directors.
Dr. Azar brings extensive leadership experience and clinical expertise in ophthalmology, biotechnology, and translational medicine. He currently serves as Distinguished Professor of Ophthalmology at the University of Illinois College of Medicine and as President and CEO of Lacristat.AI. Dr. Azar has served on the Board of Directors of Novartis, the Scientific Advisory Board at Verily, Alphabet's life sciences research arm, and the Board of Verb Surgical, a joint venture between Verily and Johnson & Johnson.
Previously, Dr. Azar was Senior Director at Verily and Founding CEO of Twenty Twenty Therapeutics, a joint venture between Santen and Verily, where he led the development of multiple novel diagnostic and therapeutic technologies in gla...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
